CBL
CBL Chairman Stephen Lebovitz Sells $2.6M in Shares
Stephen Lebovitz sold 50,000 CBL & Associates shares on the open market at about $52.73 to $53.47 apiece, leaving him with 507,019 shares.
News from SEC filings, FDA decisions and company releases, drafted with AI and checked by an editor before publication. How we work: redfiled.com/how-we-work/
CBL
Stephen Lebovitz sold 50,000 CBL & Associates shares on the open market at about $52.73 to $53.47 apiece, leaving him with 507,019 shares.
Earnings
The Grasse-based fragrance and natural ingredients group saw margins narrow on investment spending, and targets 3% to 5% organic growth for 2026.
Contract
The Swedish chemical identification specialist will deliver instruments and software in the fourth quarter of 2026, with the US Army as end customer.
Earnings
First-half revenue fell 11.1% to €400.3 million and the net loss attributable to the group widened to €24.5 million as Solutions30 exits a loss-making French telecom contract.
Earnings
The French animal health group posted 7.4% organic revenue growth, net income of €87.1 million and now aims for the upper end of its full-year range.
NVO
European regulators' advisory committee recommended marketing authorisation for denecimig, with first European launches planned for the fourth quarter of 2026.
ZBAO
The Shanghai insurtech sold a third $1M convertible note to 3i, LP and removed the floor price from all notes under its $6.7M facility.
FFAI
Faraday Future cut notes payable, derivative and payable liabilities to lift stockholders' equity by about $20 million and says it met Nasdaq's equity standard as of July 31.
PSHG
The Athens-based tanker owner delivered the 2010-built P. Aliki to new owners, netting about $30 million to help fund its newbuilding program.
LSTA
Lisata will absorb privately held Marea Therapeutics in a stock deal accompanied by a PIPE financing in Series C convertible preferred stock.
LSTA
Lisata acquires clinical-stage Marea Therapeutics in a stock-for-stock deal, pairing it with a $225 million financing that leaves legacy holders with 2.39%.
BORR
Director Tor Olav Troim bought one million Borr Drilling shares on the open market at $4.2995 apiece, lifting his stake to 30.4 million shares.